Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Curidium Medica PLC

Division of Avacta Group PLC

Latest From Curidium Medica PLC

Deals Update

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Medical Device

Deals Shaping the Medical Industry (02/2009)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions Database, providing comprehensive transaction coverage from 1991 to the present.

Vivendy makes management and board changes

Vivendy Therapeutics(Switzerland) has announced that its chief executive officer, Dr Roland Toder, is stepping down on September 30th. Vivendy has nominated Dr Gosse Bruinsma to its board, and anticipates that this nomination will be ratified at the company's next shareholder meeting. Dr Bruinsma, who most recently served as executive chairman at Curidium Medica, will also assume an executive function, which will encompass the activities of the CEO.

Switzerland Companies

Board changes at Curidium Medica

The personalised medicine company Curidium Medica (UK) has announced that Dr Gosse Bruinsma is moving from the position of chairman to that of non-executive director. Dr Barry Porter, co-founder and currently non-executive director, becomes chairman, with immediate effect.

See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Avacta Group PLC
  • Senior Management
  • Rob Smith, CFO
    Nathan Caffo, VP, Bus. Dev.
    Anne T Bruinvels, MD, PhD, CSO
  • Contact Info
  • Curidium Medica PLC
    Phone: (44) 20 7554 5100
    Studio 10, Tiger House
    Burton St.
    London, WC1H 9BY